Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage

Background and Objectives: Large cell neuroendocrine cancer is characterised by poor prognosis. The standard of treatment is still not established. The aim of this study was to assess the predictive factors of overall survival (OS) and progression-free survival (PFS) of pulmonary large cell neuroend...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowczak, Anna, Kolasinska-Cwikla, Agnieszka, Osowiecka, Karolina, Glinka, Lidia, Palucki, Jakub, Rzepko, Robert, Doboszynska, Anna, Cwikla, Jaroslaw B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911070/
https://www.ncbi.nlm.nih.gov/pubmed/33525370
http://dx.doi.org/10.3390/medicina57020118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911070/
https://www.ncbi.nlm.nih.gov/pubmed/33525370
http://dx.doi.org/10.3390/medicina57020118

Ejemplares similares